Search

everythinglearnresearchcommunity

for

Search:↓

Human Beta Defensin 1 levels do not predict the risk or severity of Alopecia Areata.

Alkylation of human hair keratin allows for adjustable drug release rates in hydrogels for medical use.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Hair greying is caused by oxidative stress damaging hair follicles and melanocytes.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Skin reactions from cancer treatments might predict how well the treatments work.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Freeze-dried dexamethasone nanoparticles in a hydrogel are stable and effective for treating alopecia areata.

Lung and liver macrophages protect our tissues and their dysfunction can cause various diseases.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Hair follicle-derived extracellular vesicles may help heal chronic wounds as effectively as those from adipose tissue.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Resveratrol may help hair grow, but more research is needed.